Figure 5

Immune status evaluation between high and low-risk groups by the nomogram model. (A–C) ESTIMATE algorithm assessing immune stroma (A), immune cells (B), and overall immune score (C) in two groups. (D,E) Cibersort and EPIC algorithms assessing 22 (D) and 8 (E) immune cell infiltration statuses in both groups. (F) TIDE algorithm estimating immune treatment response and prognosis. (G,H) Gene Set Enrichment Analysis (GSEA) of KEGG pathways (G) and oncology features (H) in the two risk groups.